Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ophthalmology (9) 9
female (8) 8
humans (8) 8
male (8) 8
photochemotherapy (8) 8
middle aged (7) 7
aged (6) 6
photosensitizing agents - therapeutic use (6) 6
porphyrins - therapeutic use (6) 6
prospective studies (6) 6
choroidal neovascularization - drug therapy (5) 5
treatment outcome (5) 5
aged, 80 and over (4) 4
angiogenesis inhibitors - therapeutic use (4) 4
antibodies, monoclonal, humanized - therapeutic use (4) 4
double-blind method (4) 4
index medicus (4) 4
photosensitizing agents - adverse effects (4) 4
porphyrins - adverse effects (4) 4
ranibizumab (4) 4
visual acuity - physiology (4) 4
age-related macular degeneration (3) 3
angiogenesis inhibitors - adverse effects (3) 3
antibodies, monoclonal, humanized - adverse effects (3) 3
choroidal neovascularization (3) 3
choroidal neovascularization - etiology (3) 3
combined modality therapy (3) 3
macular degeneration (3) 3
neovascularization (3) 3
photodynamic therapy (3) 3
physiological aspects (3) 3
visual acuity (3) 3
cancer (2) 2
choroidal neovascularization - physiopathology (2) 2
dosing regimen (2) 2
endothelial growth-factor (2) 2
fluorescein angiography (2) 2
incidence (2) 2
japanese patients (2) 2
macular degeneration - complications (2) 2
macular degeneration - drug therapy (2) 2
macular degeneration - physiopathology (2) 2
randomized clinical-trials (2) 2
tap (2) 2
verteporfin (2) 2
129497-78-5 (1) 1
347396-82-1 (1) 1
acquired immunodeficiency syndrome - complications (1) 1
administration, topical (1) 1
adults (1) 1
age related macular degeneration (1) 1
aids (1) 1
aids-related complex (1) 1
aids-related opportunistic infections - pathology (1) 1
analysis (1) 1
angio-occlusion (1) 1
anti-inflammatory agents, non-steroidal - therapeutic use (1) 1
asian continental ancestry group (1) 1
best-corrected visual acuity (1) 1
bestcorrected visual acuity (1) 1
blood-pressure control (1) 1
blood-vessels (1) 1
capillaries - pathology (1) 1
care and treatment (1) 1
causes of (1) 1
central retinal subfield thickness (1) 1
choroid - blood supply (1) 1
choroid diseases - diagnosis (1) 1
choroid diseases - drug therapy (1) 1
choroid diseases - physiopathology (1) 1
cmv (1) 1
coloring agents (1) 1
complications (1) 1
confocal scanning laser ophthalmoscope (1) 1
consulting services (1) 1
cytomegalovirus (1) 1
cytomegalovirus retinitis - etiology (1) 1
cytomegalovirus retinitis - pathology (1) 1
degeneration (1) 1
diclofenac - therapeutic use (1) 1
diclofenac sodium (1) 1
drug therapy, combination (1) 1
efficacy (1) 1
endothelium, vascular - pathology (1) 1
eye (1) 1
eye infections, fungal - complications (1) 1
eye infections, fungal - drug therapy (1) 1
factor vegf (1) 1
feasibility studies (1) 1
fovea centralis (1) 1
health management tool (1) 1
histoplasmosis - complications (1) 1
histoplasmosis - drug therapy (1) 1
hiv-infection (1) 1
immune-deficiency syndrome (1) 1
indocyanine green (1) 1
indocyanine green angiography (1) 1
intravitreal bevacizumab (1) 1
intravitreal injections (1) 1
japanese amd trial (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Everest study: Efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy
by Koh, Adrian and Lee, Won Ki and Chen, Lee-Jen and Chen, Shih-Jen and Hashad, Yehia and Kim, Hakyoung and Lai, Timothy Y and Pilz, Stefan and Ruamviboonsuk, Paisan and Tokaji, Erika and Weisberger, Annemarie and Lim, Tock H
Retina, ISSN 0275-004X, 09/2012, Volume 32, Issue 8, pp. 1453 - 1464
Purpose: To assess the effects of verteporfin photodynamic therapy (PDT) combined with ranibizumab or alone versus ranibizumab monotherapy in patients with... 
angio-occlusion | indocyanine green angiography | verteporfin PDT | polyp regression | polypoidalchoroidal vasculopathy | confocal scanning laser ophthalmoscope | ranibizumab | polypoidal choroidal vasculopathy | SUBMACULAR HEMORRHAGE | DEGENERATION | OPHTHALMOLOGY | INTRAVITREAL BEVACIZUMAB | NEOVASCULARIZATION | OUTCOMES | JAPANESE PATIENTS | Polyps - diagnosis | Intravitreal Injections | Photosensitizing Agents - therapeutic use | Coloring Agents | Humans | Middle Aged | Male | Photosensitizing Agents - adverse effects | Photochemotherapy | Choroid Diseases - drug therapy | Ranibizumab | Angiogenesis Inhibitors - therapeutic use | Female | Choroid Diseases - physiopathology | Angiogenesis Inhibitors - adverse effects | Visual Acuity - physiology | Fluorescein Angiography | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Porphyrins - therapeutic use | Double-Blind Method | Choroid - blood supply | Indocyanine Green | Treatment Outcome | Combined Modality Therapy | Polyps - physiopathology | Polyps - drug therapy | Porphyrins - adverse effects | Aged | Choroid Diseases - diagnosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: Twelve-month results of the DENALI study
by Kaiser, Peter K and Boyer, David S and Cruess, Alan F and Slakter, Jason S and Pilz, Stefan and Weisberger, Annemarie and DENALI Study Grp and DENALI Study Group
Ophthalmology, ISSN 0161-6420, 05/2012, Volume 119, Issue 5, pp. 1001 - 1010
Purpose: To demonstrate noninferiority of ranibizumab in combination with verteporfin photodynamic therapy (PDT) versus ranibizumab monotherapy in patients... 
OPHTHALMOLOGY | TAP | DOSING REGIMEN | PHOTODYNAMIC THERAPY | RANDOMIZED CLINICAL-TRIAL | ENDOTHELIAL GROWTH-FACTOR | Prospective Studies | Photosensitizing Agents - therapeutic use | Humans | Middle Aged | Male | Photosensitizing Agents - adverse effects | Photochemotherapy | Macular Degeneration - drug therapy | Incidence | Choroidal Neovascularization - drug therapy | Ranibizumab | Angiogenesis Inhibitors - therapeutic use | Female | Angiogenesis Inhibitors - adverse effects | Visual Acuity - physiology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Porphyrins - therapeutic use | Double-Blind Method | Macular Degeneration - physiopathology | Treatment Outcome | Combined Modality Therapy | Choroidal Neovascularization - physiopathology | Porphyrins - adverse effects | Aged
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: Twelve-month MONT BLANC study results
by Larsen, Michael and Schmidt-Erfurth, Ursula and Lanzetta, Paolo and Wolf, Sebastian and Simader, Christian and Tokaji, Erika and Pilz, Stefan and Weisberger, Annemarie and MONT BLANC Study Grp and MONT BLANC Study Group
Ophthalmology, ISSN 0161-6420, 05/2012, Volume 119, Issue 5, pp. 992 - 1000
Purpose: To compare the efficacy and safety of same-day verteporfin photodynamic therapy (PDT) and intravitreal ranibizumab combination treatment versus... 
FACTOR VEGF | OCCULT | PHOTODYNAMIC THERAPY | EFFICACY | OPHTHALMOLOGY | DOSING REGIMEN | RANDOMIZED CLINICAL-TRIALS | ENDOTHELIAL GROWTH-FACTOR | Prospective Studies | Photosensitizing Agents - therapeutic use | Humans | Middle Aged | Male | Photosensitizing Agents - adverse effects | Photochemotherapy | Macular Degeneration - drug therapy | Incidence | Choroidal Neovascularization - drug therapy | Ranibizumab | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Female | Angiogenesis Inhibitors - adverse effects | Visual Acuity - physiology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Porphyrins - therapeutic use | Double-Blind Method | Macular Degeneration - physiopathology | Treatment Outcome | Combined Modality Therapy | Choroidal Neovascularization - physiopathology | Porphyrins - adverse effects | Aged
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Verteporfin plus Ranibizumab for Choroidal Neovascularization in Age-related Macular Degeneration
by Larsen, Michael, MD, DMSC and Schmidt-Erfurth, Ursula, MD and Lanzetta, Paolo, MD and Wolf, Sebastian, MD, PhD and Simader, Christian, MD and Tokaji, Erika, PhD and Pilz, Stefan, PhD and Weisberger, Annemarie, MD
Ophthalmology, ISSN 0161-6420, 2012, Volume 119, Issue 5, pp. 992 - 1000
Purpose To compare the efficacy and safety of same-day verteporfin photodynamic therapy (PDT) and intravitreal ranibizumab combination treatment versus... 
Ophthalmology | Macular degeneration | Physiological aspects | Neovascularization | Photochemotherapy | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Verteporfin plus Ranibizumab for Choroidal Neovascularization in Age-Related Macular Degeneration
by Kaiser, Peter K., MD and Boyer, David S., MD and Cruess, Alan F., MD and Slakter, Jason S., MD and Pilz, Stefan, PhD and Weisberger, Annemarie, MD
Ophthalmology, ISSN 0161-6420, 2012, Volume 119, Issue 5, pp. 1001 - 1010
Purpose To demonstrate noninferiority of ranibizumab in combination with verteporfin photodynamic therapy (PDT) versus ranibizumab monotherapy in patients with... 
Ophthalmology | Macular degeneration | Analysis | Physiological aspects | Neovascularization | Photochemotherapy | Consulting services | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text FEASIBILITY OF A NOVEL REMOTE DAILY MONITORING SYSTEM FOR AGE-RELATED MACULAR DEGENERATION USING MOBILE HANDHELD DEVICES
: Results of a Pilot Study
by Kaiser, Peter K and Wang, Yi-Zhong and He, Yu-Guang and Weisberger, Annemarie and Wolf, Stephane and Smith, Craig H
Retina, ISSN 0275-004X, 10/2013, Volume 33, Issue 9, pp. 1863 - 1870
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text FEasibility of a novel remote daily monitoring system for age-related macular degeneration using mobile handheld deviCES: Results of a pilot study
by Kaiser, Peter K and Wang, Yi-Zhong and He, Yu-Guang and Weisberger, Annemarie and Wolf, Stephane and Smith, Craig H
Retina, ISSN 0275-004X, 10/2013, Volume 33, Issue 9, pp. 1863 - 1870
Purpose: This pilot study evaluated the feasibility of the Health Management Tool (HMT), a novel computing system using mobile handheld devices, to remotely... 
bestcorrected visual acuity | retinal disease | choroidal neovascularization | Health Management Tool | shape discriminationhyperacuity | myVisionTrack | remotemonitoring | age-related macular degeneration | central retinal subfield thickness | ranibizumab | best-corrected visual acuity | OPHTHALMOLOGY | BLOOD-PRESSURE CONTROL | remote monitoring | shape discrimination hyperacuity | SUBGROUP ANALYSIS | Self Care - instrumentation | Monitoring, Ambulatory - instrumentation | Antibodies, Monoclonal, Humanized - therapeutic use | Prospective Studies | Humans | Middle Aged | Vision Tests - instrumentation | Male | Wet Macular Degeneration - physiopathology | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Feasibility Studies | Patient Satisfaction | Wet Macular Degeneration - diagnosis | Pilot Projects | Wet Macular Degeneration - drug therapy | Ranibizumab | Remote Sensing Technology - instrumentation | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Female | Surveys and Questionnaires | Aged | Patient Compliance | Visual Acuity - physiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration (AMD): Results of the Japanese AMD Trial (JAT) extension
by Ohji, Masahito and Japanese Age Related Macular and Japanese Age-Related Macular Degeneration Trial (JAT) Study Group
Japanese Journal of Ophthalmology, ISSN 0021-5155, 4/2008, Volume 52, Issue 2, pp. 99 - 107
To evaluate the longer term safety of verteporfin therapy in Japanese patients with subfoveal classic choroidal neovascularization (CNV) due to age-related... 
Medicine & Public Health | choroidal neovascularization | verteporfin | Japanese AMD trial | Japanese patients | Ophthalmology | age-related macular degeneration | Verteporfin | Choroidal neovascularization | Age-related macular degeneration | EYE | TAP | VISUAL IMPAIRMENT | ADULTS | OPHTHALMOLOGY | PREVALENCE | RANDOMIZED CLINICAL-TRIALS | Porphyrins - therapeutic use | Prospective Studies | Photosensitizing Agents - therapeutic use | Fovea Centralis | Humans | Macular Degeneration - complications | Middle Aged | Choroidal Neovascularization - etiology | Male | Photosensitizing Agents - adverse effects | Treatment Outcome | Visual Acuity | Photochemotherapy | Asian Continental Ancestry Group | Choroidal Neovascularization - drug therapy | Aged, 80 and over | Porphyrins - adverse effects | Female | Aged | Fluorescein Angiography | Macular degeneration | Physiological aspects | Care and treatment | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Effect of adjunctive diclofenac with verteporfin therapy to treat choroidal neovascularization due to age-related macular degeneration: Phase II study
by Beer, Paul M and Blodi, Barbara A and Boyer, David S and Bradford, Reagan H and Chen, Sanford and Googe Jr, Joseph M and Halperin, Lawrence S and Harvey, Patricia T and Joffe, Leonard and Marx, Jeffrey L and Mieler, William F and Vander, James F and Wong, Keye L and Yoser, Seth L and Adjunctive Diclofenac with Verteporfin (ADD-V) Study Group and ADJUNCTIVE DICLOFENAC WITH VERTEPORFIN (ADD-V) STUDY GROUP
Retina, ISSN 0275-004X, 07/2007, Volume 27, Issue 6, pp. 693 - 700
To determine short-term effects of topical diclofenac administered in conjunction with verteporfin therapy for predominantly classic subfoveal choroidal... 
Diclofenac sodium | Choroidal neovascularization | Age-related macular degeneration | Verteporfin therapy | Diclofenac - therapeutic use | Porphyrins - therapeutic use | Prospective Studies | Double-Blind Method | Photosensitizing Agents - therapeutic use | Ophthalmic Solutions - therapeutic use | Humans | Macular Degeneration - complications | Middle Aged | Choroidal Neovascularization - etiology | Male | Treatment Outcome | Visual Acuity | Photochemotherapy | Choroidal Neovascularization - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Aged, 80 and over | Female | Aged | Drug Therapy, Combination | Administration, Topical
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Verteporfin Therapy for CNV Secondary to OHS
by Saperstein, David A and Rosenfeld, Philip J and Bressler, Neil M and Rosa, Robert H and Sternberg, Paul and Aaberg, Thomas M and Weisberger, Annemarie
Ophthalmology, ISSN 0161-6420, 2006, Volume 113, Issue 12, pp. 2371.e1 - 2371.e3
PHOTODYNAMIC THERAPY | OPHTHALMOLOGY | OCULAR HISTOPLASMOSIS | Porphyrins - therapeutic use | Prospective Studies | Photosensitizing Agents - therapeutic use | Humans | Middle Aged | Choroidal Neovascularization - etiology | Male | Eye Infections, Fungal - complications | Visual Acuity | Photochemotherapy | Histoplasmosis - complications | Syndrome | Retreatment | Choroidal Neovascularization - drug therapy | Eye Infections, Fungal - drug therapy | Female | Histoplasmosis - drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. A quantitative and cartographic study of retinal microvasculopathy in acquired immunodeficiency syndrome
by Glasgow, B.J and Weisberger, A.K
American Journal of Ophthalmology, ISSN 0002-9394, 1994, Volume 118, Issue 1, pp. 46 - 56
We quantified the retinal microvascular abnormalities in 57 eyes from autopsy patients with the acquired immunodeficiency syndrome (AIDS) and in 24 eyes from... 
VIRUS-INFECTION | HIV-INFECTION | AIDS-RELATED COMPLEX | OCULAR DISEASE | OPHTHALMOLOGY | IMMUNE-DEFICIENCY SYNDROME | CYTOMEGALOVIRUS | RETINITIS | CMV | Retinal Vessels - pathology | AIDS-Related Opportunistic Infections - pathology | Capillaries - pathology | Retinal Diseases - complications | Humans | Cytomegalovirus Retinitis - etiology | Cytomegalovirus Retinitis - pathology | Retinal Diseases - pathology | Endothelium, Vascular - pathology | Female | Male | Acquired Immunodeficiency Syndrome - complications
Journal Article
Details down arrow
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.